Bob S. Carter
No Rating Available
(Learn About Our Rating System)

Bob S. Carter, MD, PhD, FAANS

Languages spoken: English

Clinical Locations

Primary Location

Clinical Neurosciences Center

175 North Medical Drive East
Salt Lake City , UT 84132
801-585-7575
Get Directions

Specialties

Board Certification and Academic Information

Academic Departments Neurosurgery -Professor

Education history

Undergraduate Chemistry - Brigham Young University B.A.
Professional Medical Medicine - Johns Hopkins University School of Medicine M.D.
Graduate Training Genetic Epidemiology - Johns Hopkins University School of Public Health Ph.D.
Internship Surgery - Massachusetts General Hospital Intern
Residency Neurosurgery - Massachusetts General Hospital Resident
Fellowship Gene Therapy - Massachusetts Institute of Technology & Boston Children¿s Hospital Postdoctoral Fellow
Residency North Neurosurgical Service - Massachusetts General Hospital Chief Resident
Graduate Training Harvard University M.A.

Selected Publications

Journal Article

  1. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield X (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature cell biology, 10(12), 1470-6.
  2. Chen WW, Balaj L, Liau LM, Samuels ML, Kotsopoulos SK, Maguire CA, Loguidice L, Soto H, Garrett M, Zhu LD, Sivaraman S, Chen C, Wong ET, Carter BS, Hochberg FH, Breakefield XO, Skog (2013). BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Molecular therapy. Nucleic acids, 2(7), e109.
  3. Noerholm M, Balaj L, Limperg T, Salehi A, Zhu LD, Hochberg FH, Breakefield XO, Carter BS, Skog (2012). RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC cancer, 12, 22.
  4. Shao H, Chung J, Lee K, Balaj L, Min C, Carter BS, Hochberg FH, Breakefield XO, Lee H, Weissleder (2015). Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nature communications, 6, 6999.
  5. Muralidharan K, Yekula A, Small JL, Rosh ZS, Kang KM, Wang L, Lau S, Zhang H, Lee H, Bettegowda C, Chicoine MR, Kalkanis SN, Shankar GM, Nahed BV, Curry WT, Jones PS, Cahill DP, Balaj L, Carter B (2021). TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas. Clinical cancer research, 27(1), 169-178.
  6. Batool SM, Muralidharan K, Hsia T, Falotico S, Gamblin AS, Rosenfeld YB, Khanna SK, Balaj L, Carter B (2022). Highly Sensitive EGFRvIII Detection in Circulating Extracellular Vesicle RNA of Glioma Patients. Clinical cancer research, 28(18), 4070-4082.
  7. Kuo CJ, Farnebo F, Yu EY, Christofferson R, Swearingen RA, Carter R, von Recum HA, Yuan J, Kamihara J, Flynn E, D'Amato R, Folkman J, Mulligan R (2001). Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proceedings of the National Academy of Sciences of the United States of America, 98(8), 4605-10.
  8. Sanchez CE, Tierney TS, Gale JT, Alavian KN, Sahin A, Lee JS, Mulligan RC, Carter B (2011). Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation. Journal of neurosurgery, 114(3), 672-80.
  9. Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, Kim K (2020). Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease. The New England journal of medicine, 382(20), 1926-1932.
  10. Park TY, Jeon J, Lee N, Kim J, Song B, Kim JH, Lee SK, Liu D, Cha Y, Kim M, Leblanc P, Herrington TM, Carter BS, Schweitzer JS, Kim K (2023). Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson's disease. Nature, 619(7970), 606-615.
  11. Bullain SS, Sahin A, Szentirmai O, Sanchez C, Lin N, Baratta E, Waterman P, Weissleder R, Mulligan RC, Carter B (2009). Genetically engineered T cells to target EGFRvIII expressing glioblastoma. Journal of neuro-oncology, 94(3), 373-82.
  12. Kong S, Sengupta S, Tyler B, Bais AJ, Ma Q, Doucette S, Zhou J, Sahin A, Carter BS, Brem H, Junghans RP, Sampath (2012). Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. Clinical cancer research, 18(21), 5949-60.
  13. Sahin A, Sanchez C, Bullain S, Waterman P, Weissleder R, Carter B (2018). Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma. PloS one, 13(7), e0199414.
  14. Choi BD, Yu X, Castano AP, Bouffard AA, Schmidts A, Larson RC, Bailey SR, Boroughs AC, Frigault MJ, Leick MB, Scarfò I, Cetrulo CL, Demehri S, Nahed BV, Cahill DP, Wakimoto H, Curry WT, Carter BS, Maus M (2019). CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nature biotechnology, 37(9), 1049-1058.
  15. Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT, Gallagher K, Maus M (2024). Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma. The New England journal of medicine, 390(14), 1290-1298.
  16. Carter BS, Carter HB, Isaacs J (1990). Epidemiologic evidence regarding predisposing factors to prostate cancer. The Prostate, 16(3), 187-97.
  17. Carter BS, Epstein JI, Isaacs W (1990). Ras gene mutations in human prostate cancer. Cancer research, 50(21), 6830-2.
  18. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh P (1990). Family history and the risk of prostate cancer. The Prostate, 17(4), 337-47.
  19. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs W (1990). Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 87(22), 8751-5.
  20. Quinlan DM, Epstein JI, Carter BS, Walsh P (1991). Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. The Journal of urology, 145(5), 998-1002.
  21. Isaacs WB, Carter BS, Ewing C (1991). Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer research, 51(17), 4716-20.
  22. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh P (1993). Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer research, 53(17), 3869-73.
  23. Brooks JD, Bova GS, Ewing CM, Piantadosi S, Carter BS, Robinson JC, Epstein JI, Isaacs W (1996). An uncertain role for p53 gene alterations in human prostate cancers. Cancer research, 56(16), 3814-22.
  24. Ogilvy CS, Carter BS, Kaplan S, Rich C, Crowell R (1996). Temporary vessel occlusion for aneurysm surgery: risk factors for stroke in patients protected by induced hypothermia and hypertension and intravenous mannitol administration. Journal of neurosurgery, 84(5), 785-91.
  25. Carter BS, Ogilvy CS, Candia GJ, Rosas HD, Buonanno (1997). One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery, 40(6), 1168-75; discussion 1175-6.
  26. Bova GS, Partin AW, Isaacs SD, Carter BS, Beaty TL, Isaacs WB, Walsh P (1998). Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy. The Journal of urology, 160(3 Pt 1), 660-3.
  27. Carter BS, Zervas NT, Chiocca E (1999). Neurogenetic surgery: current limitations and the promise of gene- and virus-based therapies. Clinical neurosurgery, 45, 226-46.
  28. Ogilvy CS, Carter B (1998). A proposed comprehensive grading system to predict outcome for surgical management of intracranial aneurysms. Neurosurgery, 42(5), 959-68; discussion 968-70.
  29. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak AM, Mulligan RC, Dvorak H (2000). Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Laboratory investigation; a journal of technical methods and pathology, 80(1), 99-115.
  30. Carter BS, Buckley D, Ferraro R, Rordorf G, Ogilvy C (2000). Factors associated with reintegration to normal living after subarachnoid hemorrhage. Neurosurgery, 46(6), 1326-33; discussion 1333-4.
  31. Chung RY, Carter BS, Norbash A, Budzik R, Putnam C, Ogilvy C (2000). Management outcomes for ruptured and unruptured aneurysms in the elderly. Neurosurgery, 47(4), 827-32; discussion 832-3.
  32. Carter BS, Ogilvy CS, Putman C, Ojemann R (2000). Selective use of extracranial-intracranial bypass as an adjunct to therapeutic internal carotid artery occlusion. Clinical neurosurgery, 46, 351-62.
  33. Snitkovsky S, Niederman TM, Carter BS, Mulligan RC, Young J (2000). A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor. Journal of virology, 74(20), 9540-5.
  34. McDonald CT, Carter BS, Putman C, Ogilvy C (2001). Subarachnoid Hemorrhage. Current treatment options in cardiovascular medicine, 3(5), 429-439.
  35. Hoh BL, Carter BS, Budzik RF, Putman CM, Ogilvy C (2001). Results after surgical and endovascular treatment of paraclinoid aneurysms by a combined neurovascular team. Neurosurgery, 48(1), 78-89; discussion 89-90.
  36. Hoh BL, Putman CM, Budzik RF, Carter BS, Ogilvy C (2001). Combined surgical and endovascular techniques of flow alteration to treat fusiform and complex wide-necked intracranial aneurysms that are unsuitable for clipping or coil embolization. Journal of neurosurgery, 95(1), 24-35.
  37. Hoh BL, Carter BS, Ogilvy C (2002). Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy. Neurosurgery, 50(6), 1207-11; discussion 1211-2.
  38. Smith ER, Carter BS, Ogilvy C (2002). Proposed use of prophylactic decompressive craniectomy in poor-grade aneurysmal subarachnoid hemorrhage patients presenting with associated large sylvian hematomas. Neurosurgery, 51(1), 117-24; discussion 124.
  39. Hoh BL, Chapman PH, Loeffler JS, Carter BS, Ogilvy C (2002). Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery, 51(2), 303-9; discussion 309-11.
  40. Ogilvy CS, Carter B (2003). Stratification of outcome for surgically treated unruptured intracranial aneurysms. Neurosurgery, 52(1), 82-7; discussion 87-8.
  41. Hoh BL, Rabinov JD, Pryor JC, Carter BS, Barker FG 2n (2003). In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000: effect of hospital and physician volume. AJNR. American journal of neuroradiology, 24(7), 1409-20.
  42. Barker FG 2nd, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter B (2003). In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996-2000: the effect of hospital and surgeon volume. Neurosurgery, 52(5), 995-1007; discussion 1007-9.
  43. Hoh BL, Carter BS, Putman CM, Ogilvy C (2003). Important factors for a combined neurovascular team to consider in selecting a treatment modality for patients with previously clipped residual and recurrent intracranial aneurysms. Neurosurgery, 52(4), 732-8; discussion 738-9.
  44. Kalkanis SN, Eskandar EN, Carter BS, Barker FG 2n (2003). Microvascular decompression surgery in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of hospital and surgeon volumes. Neurosurgery, 52(6), 1251-61; discussion 1261-2.
  45. Topcuoglu MA, Ogilvy CS, Carter BS, Buonanno FS, Koroshetz WJ, Singhal A (2003). Subarachnoid hemorrhage without evident cause on initial angiography studies: diagnostic yield of subsequent angiography and other neuroimaging tests. Journal of neurosurgery, 98(6), 1235-40.
  46. Barker FG 2nd, Amin-Hanjani S, Butler WE, Hoh BL, Rabinov JD, Pryor JC, Ogilvy CS, Carter B (2004). Age-dependent differences in short-term outcome after surgical or endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000. Neurosurgery, 54(1), 18-28; discussion 28-30.
  47. Chen C, Carter B (2004). Hemicraniectomy for massive cerebral infarction. Topics in stroke rehabilitation, 11(2), 7-11.
  48. Hoh BL, Carter BS, Ogilvy C (2004). Incidence of residual intracranial AVMs after surgical resection and efficacy of immediate surgical re-exploration. Acta neurochirurgica, 146(1), 1-7; discussion 7.
  49. Szentirmai O, Carter B (2004). Genetic and cellular therapies for cerebral infarction. Neurosurgery, 55(2), 283-6; discussion 296-7.
  50. Hoh BL, Cheung AC, Rabinov JD, Pryor JC, Carter BS, Ogilvy C (2004). Results of a prospective protocol of computed tomographic angiography in place of catheter angiography as the only diagnostic and pretreatment planning study for cerebral aneurysms by a combined neurovascular team. Neurosurgery, 54(6), 1329-40; discussion 1340-2.
  51. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, Rordorf G (2004). Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR. American journal of neuroradiology, 25(5), 819-26.
  52. Hoh BL, Curry WT Jr, Carter BS, Ogilvy C (2004). Computed tomographic demonstrated infarcts after surgical and endovascular treatment of aneurysmal subarachnoid hemorrhage. Acta neurochirurgica, 146(11), 1177-83.
  53. Hoh BL, Topcuoglu MA, Singhal AB, Pryor JC, Rabinov JD, Rordorf GA, Carter BS, Ogilvy C (2004). Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery, 55(4), 779-86; discussion 786-9.
  54. Barker FG 2nd, Curry WT Jr, Carter B (2005). Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro-oncology, 7(1), 49-63.
  55. Barker FG 2nd, Carter B (2005). Synthesizing medical evidence: systematic reviews and metaanalyses. Neurosurgical focus, 19(4), E5.
  56. Singhal AB, Topcuoglu MA, Dorer DJ, Ogilvy CS, Carter BS, Koroshetz W (2005). SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology, 64(6), 1008-13.
  57. Curry WT Jr, Sethi MK, Ogilvy CS, Carter B (2005). Factors associated with outcome after hemicraniectomy for large middle cerebral artery territory infarction. Neurosurgery, 56(4), 681-92; discussion 681-92.
  58. Badjatia N, O'Donnell J, Baker JR, Huang D, Ayata C, Greer DM, Carter BS, Ogilvy CS, McDonald C (2004). Achieving normothermia in patients with febrile subarachnoid hemorrhage: feasibility and safety of a novel intravascular cooling catheter. Neurocritical care, 1(2), 145-56.
  59. Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, Carter BS, Ogilvy CS, Singhal A (2005). Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Critical care medicine, 33(7), 1603-9; quiz 1623.
  60. Curry WT, McDermott MW, Carter BS, Barker FG 2n (2005). Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. Journal of neurosurgery, 102(6), 977-86.
  61. Magavi SS, Mitchell BD, Szentirmai O, Carter BS, Macklis J (2005). Adult-born and preexisting olfactory granule neurons undergo distinct experience-dependent modifications of their olfactory responses in vivo. The Journal of neuroscience, 25(46), 10729-39.
  62. Szentirmai O, Baker CH, Lin N, Szucs S, Takahashi M, Kiryu S, Kung AL, Mulligan RC, Carter B (2006). Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery, 58(2), 365-72; discussion 365-72.
  63. Carter BS, Sheth S, Chang E, Sethl M, Ogilvy C (2006). Epidemiology of the size distribution of intracranial bifurcation aneurysms: smaller size of distal aneurysms and increasing size of unruptured aneurysms with age. Neurosurgery, 58(2), 217-23; discussion 217-23.
  64. Ledezma CJ, Hoh BL, Carter BS, Pryor JC, Putman CM, Ogilvy C (2006). Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery, 58(4), 602-11; discussion 602-11.
  65. Ogilvy CS, Cheung AC, Mitha AP, Hoh BL, Carter B (2006). Outcomes for surgical and endovascular management of intracranial aneurysms using a comprehensive grading system. Neurosurgery, 59(5), 1037-42; discussion 1043.
  66. Aghi MK, Eskandar EN, Carter BS, Curry WT Jr, Barker FG 2n (2007). Increased prevalence of obesity and obesity-related postoperative complications in male patients with meningiomas. Neurosurgery, 61(4), 754-60; discussion 760-1.
  67. Sanchez CE, Ogilvy CS, Carter B (2007). Outcomes studies in cerebrovascular neurosurgery. Neurosurgical focus, 22(3), E11.
  68. Nogueira RG, Bodock MJ, Koroshetz WJ, Topcuoglu MA, Carter BS, Ogilvy CS, Pryor JC, Buonanno F (2007). High-dose bosentan in the prevention and treatment of subarachnoid hemorrhage-induced cerebral vasospasm: an open-label feasibility study. Neurocritical care, 7(3), 194-202.
  69. Huang YQ, Sauthoff H, Herscovici P, Pipiya T, Cheng J, Heitner S, Szentirmai O, Carter B, Hay J (2008). Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury. Critical care medicine, 36(1), 262-7.
  70. Szentirmai O, Baker CH, Bullain SS, Lin N, Takahashi M, Folkman J, Mulligan RC, Carter B (2008). Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation. Journal of neurosurgery, 108(5), 979-88.
  71. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield X (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature cell biology, 10(12), 1470-6.
  72. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG 2n (2009). Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery, 64(1), 56-60; discussion 60.
  73. Latorre JG, Chou SH, Nogueira RG, Singhal AB, Carter BS, Ogilvy CS, Rordorf G (2009). Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke, 40(5), 1644-52.
  74. Bullain SS, Sahin A, Szentirmai O, Sanchez C, Lin N, Baratta E, Waterman P, Weissleder R, Mulligan RC, Carter B (2009). Genetically engineered T cells to target EGFRvIII expressing glioblastoma. Journal of neuro-oncology, 94(3), 373-82.
  75. Carter BS, Farrell C, Owen (2009). Microsurgical clip obliteration of middle cerebral aneurysm using intraoperative flow assessment. Journal of visualized experiments, (31),
  76. Chen C, Skog J, Hsu CH, Lessard RT, Balaj L, Wurdinger T, Carter BS, Breakefield XO, Toner M, Irimia (2010). Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab on a chip, 10(4), 505-11.
  77. Curry WT Jr, Carter BS, Barker FG 2n (2010). Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988-2004. Neurosurgery, 66(3), 427-37; discussion 437-8.
  78. Grandi P, Fernandez J, Szentirmai O, Carter R, Gianni D, Sena-Esteves M, Breakefield X (2010). Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cells. Cancer gene therapy, 17(9), 655-63.
  79. Babu MA, Coumans JV, Carter BS, Taylor WR, Kasper EM, Roitberg BZ, Krauss WE, Chen C (2011). A review of lumbar spinal instrumentation: evidence and controversy. Journal of neurology, neurosurgery, and psychiatry, 82(9), 948-51.
  80. Sanchez CE, Tierney TS, Gale JT, Alavian KN, Sahin A, Lee JS, Mulligan RC, Carter B (2011). Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation. Journal of neurosurgery, 114(3), 672-80.
  81. Ramakrishnan V, Kushwaha D, Koay DC, Reddy H, Mao Y, Zhou L, Ng K, Zinn P, Carter B, Chen C (2011). Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas. Cancer biomarkers, 10(3-4), 185-93.
  82. Chen T, Carter B (2011). Role of magnesium sulfate in aneurysmal subarachnoid hemorrhage management: A meta-analysis of controlled clinical trials. Asian journal of neurosurgery, 6(1), 26-31.
  83. Rabinov JD, Yoo AJ, Ogilvy CS, Carter BS, Hirsch J (2013). ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas. Journal of neurointerventional surgery, 5(4), 306-10.
  84. Noerholm M, Balaj L, Limperg T, Salehi A, Zhu LD, Hochberg FH, Breakefield XO, Carter BS, Skog (2012). RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC cancer, 12, 22.
  85. Kesari S, Advani SJ, Lawson JD, Kahle KT, Ng K, Carter B, Chen C (2011). DNA damage response and repair: insights into strategies for radiation sensitization of gliomas. Future oncology (London, England), 7(11), 1335-46.
  86. Gonda DD, Kim TE, Warnke PC, Kasper EM, Carter BS, Chen C (2012). Ventriculoperitoneal shunting versus endoscopic third ventriculostomy in the treatment of patients with hydrocephalus related to metastasis. Surgical neurology international, 3, 97.
  87. Kong S, Sengupta S, Tyler B, Bais AJ, Ma Q, Doucette S, Zhou J, Sahin A, Carter BS, Brem H, Junghans RP, Sampath (2012). Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. Clinical cancer research, 18(21), 5949-60.
  88. Waters JD, Sanchez C, Sahin A, Futalan D, Gonda DD, Scheer JK, Akers J, Palanichamy K, Waterman P, Chakravarti A, Weissleder R, Morse B, Marsh N, Furfine E, Chen CC, Carvajal I, Carter B (2012). CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy. Journal of neuro-oncology, 110(1), 37-48.
  89. Pan H, Cerviño LI, Pawlicki T, Jiang SB, Alksne J, Detorie N, Russell M, Carter BS, Murphy KT, Mundt AJ, Chen C, Lawson J (2012). Frameless, real-time, surface imaging-guided radiosurgery: clinical outcomes for brain metastases. Neurosurgery, 71(4), 844-51.
  90. Chen WW, Balaj L, Liau LM, Samuels ML, Kotsopoulos SK, Maguire CA, Loguidice L, Soto H, Garrett M, Zhu LD, Sivaraman S, Chen C, Wong ET, Carter BS, Hochberg FH, Breakefield XO, Skog (2013). BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Molecular therapy. Nucleic acids, 2(7), e109.
  91. McDuff SG, Taich ZJ, Lawson JD, Sanghvi P, Wong ET, Barker FG 2nd, Hochberg FH, Loeffler JS, Warnke PC, Murphy KT, Mundt AJ, Carter BS, McDonald CR, Chen C (2013). Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases. Journal of neurology, neurosurgery, and psychiatry, 84(12), 1384-91.
  92. Waters JD, Rose B, Gonda DD, Scanderbeg DJ, Russell M, Alksne JF, Murphy K, Carter BS, Lawson J, Chen C (2013). Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma. Journal of neuro-oncology, 113(3), 467-77.
  93. Akers JC, Gonda D, Kim R, Carter BS, Chen C (2013). Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. Journal of neuro-oncology, 113(1), 1-11.
  94. Gonda DD, Cheung VJ, Muller KA, Goyal A, Carter BS, Chen C (2014). The Cancer Genome Atlas expression profiles of low-grade gliomas. Neurosurgical focus, 36(4), E23.
  95. Gonda DD, Akers JC, Kim R, Kalkanis SN, Hochberg FH, Chen CC, Carter B (2013). Neuro-oncologic applications of exosomes, microvesicles, and other nano-sized extracellular particles. Neurosurgery, 72(4), 501-10.
  96. Saria MG, Corle C, Hu J, Rudnick JD, Phuphanich S, Mrugala MM, Crew LK, Bota DA, Dan Fu B, Kim RY, Brown T, Feely H, Brechlin J, Brown BD, Drappatz J, Wen PY, Chen CC, Carter B, Lee JW, Kesari (2013). Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article. Journal of neurosurgery, 118(6), 1183-7.
  97. McDonald CR, White NS, Farid N, Lai G, Kuperman JM, Bartsch H, Hagler DJ, Kesari S, Carter BS, Chen CC, Dale A (2013). Recovery of white matter tracts in regions of peritumoral FLAIR hyperintensity with use of restriction spectrum imaging. AJNR. American journal of neuroradiology, 34(6), 1157-63.
  98. Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS, Hochberg FH, Breakefield XO, Weissleder R, Lee (2012). Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nature medicine, 18(12), 1835-40.
  99. Noorbakhsh A, Tang JA, Marcus LP, McCutcheon B, Gonda DD, Schallhorn CS, Talamini MA, Chang DC, Carter BS, Chen C (2014). Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. Journal of neurosurgery, 120(1), 31-9.
  100. Akers JC, Ramakrishnan V, Kim R, Skog J, Nakano I, Pingle S, Kalinina J, Hua W, Kesari S, Mao Y, Breakefield XO, Hochberg FH, Van Meir EG, Carter BS, Chen C (2013). MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PloS one, 8(10), e78115.
  101. Gonda DD, Kim TE, Goetsch SJ, Kawabe T, Watanabe S, Alksne JF, Hattangadi JA, Nitta M, Ott K, Hodgens DW, Carter BS, Yamamoto M, Chen C (2014). Prognostic factors for stereotactic radiosurgery-treated patients with cerebral metastasis: implications on randomised control trial design and inter-institutional collaboration. European journal of cancer (Oxford, England, 50(6), 1148-58.
  102. Marcus LP, McCutcheon BA, Noorbakhsh A, Parina RP, Gonda DD, Chen C, Chang DC, Carter B (2014). Incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors in California (1995-2010). Journal of neurosurgery, 120(5), 1201-11.
  103. Li J, Zhu S, Kozono D, Ng K, Futalan D, Shen Y, Akers JC, Steed T, Kushwaha D, Schlabach M, Carter BS, Kwon CH, Furnari F, Cavenee W, Elledge S, Chen C (2014). Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma. Oncotarget, 5(4), 882-93.
  104. Gonda DD, Khalessi AA, McCutcheon BA, Marcus LP, Noorbakhsh A, Chen CC, Chang DC, Carter B (2014). Long-term follow-up of unruptured intracranial aneurysms repaired in California. Journal of neurosurgery, 120(6), 1349-57.
  105. Kushwaha D, Ramakrishnan V, Ng K, Steed T, Nguyen T, Futalan D, Akers JC, Sarkaria J, Jiang T, Chowdhury D, Carter BS, Chen C (2014). A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas. Oncotarget, 5(12), 4026-39.
  106. Hatefi D, Hirshman B, Leys D, Lejeune JP, Marshall L, Carter BS, Kasper E, Chen C (2014). Hemicraniectomy in the management of malignant middle cerebral artery infarction: Lessons from randomized, controlled trials. Surgical neurology international, 5, 72.
  107. Scott BJ, van Vugt VA, Rush T, Brown T, Chen CC, Carter BS, Schwab R, Fanta P, Helsten T, Bazhenova L, Parker B, Pingle S, Saria MG, Brown BD, Piccioni DE, Kesari (2014). Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study. Journal of neuro-oncology, 119(2), 361-8.
  108. White NS, McDonald C, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Carter BS, Bradley WG, Dale A (2014). Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer research, 74(17), 4638-52.
  109. McCutcheon BA, Ciacci JD, Marcus LP, Noorbakhsh A, Gonda DD, McCafferty R, Taylor W, Chen CC, Carter BS, Chang D (2015). Thirty-Day Perioperative Outcomes in Spinal Fusion by Specialty Within the NSQIP Database. Spine, 40(14), 1122-31.
  110. Steed TC, Treiber JM, Patel KS, Taich Z, White NS, Treiber ML, Farid N, Carter BS, Dale AM, Chen C (2015). Iterative probabilistic voxel labeling: automated segmentation for analysis of The Cancer Imaging Archive glioblastoma images. AJNR. American journal of neuroradiology, 36(4), 678-85.
  111. Li J, Taich ZJ, Goyal A, Gonda D, Akers J, Adhikari B, Patel K, Vandenberg S, Yan W, Bao Z, Carter BS, Wang R, Mao Y, Jiang T, Chen C (2014). Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas. Oncotarget, 5(17), 7342-56.
  112. Bao ZS, Chen HM, Yang MY, Zhang CB, Yu K, Ye WL, Hu BQ, Yan W, Zhang W, Akers J, Ramakrishnan V, Li J, Carter B, Liu YW, Hu HM, Wang Z, Li MY, Yao K, Qiu XG, Kang CS, You YP, Fan XL, Song WS, Li RQ, Su XD, Chen CC, Jiang (2014). RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome research, 24(11), 1765-73.
  113. Gilder AS, Jones KA, Hu J, Wang L, Chen CC, Carter BS, Gonias S (2015). Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion. The Journal of biological chemistry, 290(24), 14798-809.
  114. Gardiner C, Harrison P, Belting M, Böing A, Campello E, Carter BS, Collier ME, Coumans F, Ettelaie C, van Es N, Hochberg FH, Mackman N, Rennert RC, Thaler J, Rak J, Nieuwland (2015). Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day. Journal of extracellular vesicles, 4, 26901.
  115. McCutcheon BA, Chang DC, Marcus L, Gonda DD, Noorbakhsh A, Chen CC, Talamini MA, Carter B (2015). Treatment biases in traumatic neurosurgical care: a retrospective study of the Nationwide Inpatient Sample from 1998 to 2009. Journal of neurosurgery, 123(2), 406-14.
  116. Akers JC, Ramakrishnan V, Kim R, Phillips S, Kaimal V, Mao Y, Hua W, Yang I, Fu CC, Nolan J, Nakano I, Yang Y, Beaulieu M, Carter BS, Chen C (2015). miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients. Journal of neuro-oncology, 123(2), 205-16.
  117. Shao H, Chung J, Lee K, Balaj L, Min C, Carter BS, Hochberg FH, Breakefield XO, Lee H, Weissleder (2015). Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nature communications, 6, 6999.
  118. Lai G, Muller KA, Carter BS, Chen C (2015). Arteriovenous malformation within an isocitrate dehydrogenase 1 mutated anaplastic oligodendroglioma. Surgical neurology international, 6(Suppl 9), S295-9.
  119. Shen Y, Li J, Nitta M, Futalan D, Steed T, Treiber JM, Taich Z, Stevens D, Wykosky J, Chen HZ, Carter BS, Becher OJ, Kennedy R, Esashi F, Sarkaria JN, Furnari FB, Cavenee WK, Desai A, Chen C (2015). Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition. Oncotarget, 6(14), 11751-67.
  120. Laurent LC, Abdel-Mageed AB, Adelson PD, Arango J, Balaj L, Breakefield X, Carlson E, Carter BS, Majem B, Chen CC, Cocucci E, Danielson K, Courtright A, Das S, Abd Elmageed ZY, Enderle D, Ezrin A, Ferrer M, Freedman J, Galas D, Gandhi R, Huentelman MJ, Van Keuren-Jensen K, Kalani Y, Kim Y, Krichevsky AM, Lai C, Lal-Nag M, Laurent CD, Leonardo T, Li F, Malenica I, Mondal D, Nejad P, Patel T, Raffai RL, Rubio R, Skog J, Spetzler R, Sun J, Tanriverdi K, Vickers K, Wang L, Wang Y, Wei Z, Weiner HL, Wong D, Yan IK, Yeri A, Gould (2015). Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium. Journal of extracellular vesicles, 4, 26533.
  121. Quinn JF, Patel T, Wong D, Das S, Freedman JE, Laurent LC, Carter BS, Hochberg F, Van Keuren-Jensen K, Huentelman M, Spetzler R, Kalani MY, Arango J, Adelson PD, Weiner HL, Gandhi R, Goilav B, Putterman C, Saugstad J (2015). Extracellular RNAs: development as biomarkers of human disease. Journal of extracellular vesicles, 4, 27495.
  122. Subramanian SL, Kitchen RR, Alexander R, Carter BS, Cheung KH, Laurent LC, Pico A, Roberts LR, Roth ME, Rozowsky JS, Su AI, Gerstein MB, Milosavljevic (2015). Integration of extracellular RNA profiling data using metadata, biomedical ontologies and Linked Data technologies. Journal of extracellular vesicles, 4, 27497.
  123. Patel KS, Yao Y, Wang R, Carter BS, Chen C (2016). Intraoperative magnetic resonance imaging assessment of non-functioning pituitary adenomas during transsphenoidal surgery. Pituitary, 19(2), 222-31.
  124. Marcus LP, Marshall D, Hirshman BR, McCutcheon BA, Gonda DD, Koiso T, Hattangadi-Gluth JA, Carter BS, Yamamoto M, Chen C (2016). Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model. Neurosurgery, 79(2), 246-52.
  125. Hirshman BR, Tang JA, Jones LA, Proudfoot JA, Carley KM, Marshall L, Carter BS, Chen C (2016). Impact of medical academic genealogy on publication patterns: An analysis of the literature for surgical resection in brain tumor patients. Annals of neurology, 79(2), 169-77.
  126. Murphy M, Gilder H, McCutcheon BA, Kerezoudis P, Rinaldo L, Shepherd D, Maloney P, Snyder K, Carlson ML, Carter BS, Bydon M, Van Gompel JJ, Link M (2016). Increased Operative Time for Benign Cranial Nerve Tumor Resection Correlates with Increased Morbidity Postoperatively. Journal of neurological surgery. Part B, Skull base, 77(4), 350-7.
  127. Kerezoudis P, McCutcheon BA, Murphy M, Rayan T, Gilder H, Rinaldo L, Shepherd D, Maloney PR, Hirshman BR, Carter BS, Bydon M, Meyer F, Lanzino (2016). Predictors of 30-day perioperative morbidity and mortality of unruptured intracranial aneurysm surgery. Clinical neurology and neurosurgery, 149, 75-80.
  128. Akers JC, Ramakrishnan V, Yang I, Hua W, Mao Y, Carter BS, Chen C (2016). Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid. Cancer biomarkers, 17(2), 125-32.
  129. Akers JC, Ramakrishnan V, Nolan JP, Duggan E, Fu CC, Hochberg FH, Chen CC, Carter B (2016). Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF). PloS one, 11(2), e0149866.
  130. Winston CN, Goetzl EJ, Akers JC, Carter BS, Rockenstein EM, Galasko D, Masliah E, Rissman R (2016). Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimer's & dementia (Amsterdam, Netherlands), 3, 63-72.
  131. Marshall DC, Marcus LP, Kim TE, McCutcheon BA, Goetsch SJ, Koiso T, Alksne JF, Ott K, Carter BS, Hattangadi-Gluth JA, Yamamoto M, Chen C (2016). Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries. Journal of neuro-oncology, 128(1), 119-128.
  132. Kalinina J, Ahn J, Devi NS, Wang L, Li Y, Olson JJ, Glantz M, Smith T, Kim EL, Giese A, Jensen RL, Chen CC, Carter BS, Mao H, He M, Van Meir E (2016). Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase. Clinical cancer research, 22(24), 6256-6265.
  133. Taich ZJ, Goetsch SJ, Monaco E, Carter BS, Ott K, Alksne JF, Chen C (2016). Stereotactic Radiosurgery Treatment of Trigeminal Neuralgia: Clinical Outcomes and Prognostic Factors. World neurosurgery, 90, 604-612.e11.
  134. Cloughesy TF, Landolfi J, Hogan DJ, Bloomfield S, Carter B, Chen CC, Elder JB, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu PL, Piccioni D, Walbert T, Chu A, Das A, Diago OR, Gammon D, Gruber HE, Hanna M, Jolly DJ, Kasahara N, McCarthy D, Mitchell L, Ostertag D, Robbins JM, Rodriguez-Aguirre M, Vogelbaum M (2016). Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma. Science translational medicine, 8(341), 341ra75.
  135. Wilson BR, Tringale KR, Hirshman BR, Zhou T, Umlauf A, Taylor WR, Ciacci JD, Carter BS, Chen C (2017). Depression After Spinal Surgery: A Comparative Analysis of the California Outcomes Database. Mayo Clinic proceedings, 92(1), 88-97.
  136. Hirshman BR, Jones LA, Tang JA, Proudfoot JA, Carley KM, Carter BS, Chen C (2016). 'Journal Bias' in peer-reviewed literature: an analysis of the surgical high-grade glioma literature. Journal of neurology, neurosurgery, and psychiatry, 87(11), 1248-1250.
  137. McCutcheon BA, Kerezoudis P, Porter AL, Rinaldo L, Murphy M, Maloney P, Shepherd D, Hirshman BR, Carter BS, Lanzino G, Bydon M, Meyer (2016). Coma and Stroke Following Surgical Treatment of Unruptured Intracranial Aneurysm: An American College of Surgeons National Surgical Quality Improvement Program Study. World neurosurgery, 91, 272-8.
  138. Hirshman BR, Jones LA, Carroll KT, Tang JA, Proudfoot JA, Carley KM, Carter BS, Chen C (2016). Coevolution of Peer-Reviewed Literature and Clinical Practice in High-Grade Glioma Resection. World neurosurgery, 96, 237-241.
  139. Brandel MG, Hirshman BR, McCutcheon BA, Tringale K, Carroll K, Richtand NM, Perry W, Chen CC, Carter B (2017). The Association between Psychiatric Comorbidities and Outcomes for Inpatients with Traumatic Brain Injury. Journal of neurotrauma, 34(5), 1005-1016.
  140. Vespa P, Hanley D, Betz J, Hoffer A, Engh J, Carter R, Nakaji P, Ogilvy C, Jallo J, Selman W, Bistran-Hall A, Lane K, McBee N, Saver J, Thompson RE, Martin N, ICES Investigator (2016). ICES (Intraoperative Stereotactic Computed Tomography-Guided Endoscopic Surgery) for Brain Hemorrhage: A Multicenter Randomized Controlled Trial. Stroke, 47(11), 2749-2755.
  141. Scheer JK, Hamelin T, Chang L, Lemkuil B, Carter BS, Chen C (2017). Real-time Magnetic Resonance Imaging-Guided Biopsy Using SmartFrame® Stereotaxis in the Setting of a Conventional Diagnostic Magnetic Resonance Imaging Suite. Operative neurosurgery (Hagerstown, Md.), 13(3), 329-337.
  142. Tringale KR, Wilson BR, Hirshman B, Zhou T, Folsom D, Norman MA, Grant I, Chen CC, Carter B (2016). Psychiatric Disease Preceding Intracranial Tumor Diagnosis: Investigating the Association. The primary care companion for CNS disorders, 18(6),
  143. Lau SKM, Patel K, Kim T, Knipprath E, Kim GY, Cerviño LI, Lawson JD, Murphy KT, Sanghvi P, Carter BS, Chen C (2017). Clinical efficacy and safety of surface imaging guided radiosurgery (SIG-RS) in the treatment of benign skull base tumors. Journal of neuro-oncology, 132(2), 307-312.
  144. Figueroa JM, Skog J, Akers J, Li H, Komotar R, Jensen R, Ringel F, Yang I, Kalkanis S, Thompson R, LoGuidice L, Berghoff E, Parsa A, Liau L, Curry W, Cahill D, Bettegowda C, Lang FF, Chiocca EA, Henson J, Kim R, Breakefield X, Chen C, Messer K, Hochberg F, Carter B (2017). Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients. Neuro-oncology, 19(11), 1494-1502.
  145. Brandel MG, Alattar AA, Hirshman BR, Dong X, Carroll KT, Ali MA, Carter BS, Chen C (2017). Survival trends of oligodendroglial tumor patients and associated clinical practice patterns: a SEER-based analysis. Journal of neuro-oncology, 133(1), 173-181.
  146. Schupper AJ, Hirshman BR, Carroll KT, Ali MA, Carter BS, Chen C (2017). Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis. World neurosurgery, 103, 741-747.
  147. Steinberg JA, Carter BS, Lee MB, Steinberg G (2017). Ipsilateral Pupillary Dilation Following Carotid Endarterectomy: A Temporary and Benign Phenomenon. Neurosurgery, 80(5), E239-E244.
  148. Scheer JK, Hamelin T, Chang L, Lemkuil B, Carter BS, Chen C (2017). Real-time Magnetic Resonance Imaging-Guided Biopsy Using SmartFrame® Stereotaxis in the Setting of a Conventional Diagnostic Magnetic Resonance Imaging Suite. Operative neurosurgery (Hagerstown, Md.), 13(3), 329-337.
  149. Carroll KT, Hirshman B, Ali MA, Alattar AA, Brandel MG, Lochte B, Lanman T, Carter B, Chen C (2017). Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis. World neurosurgery, 103, 186-193.
  150. Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H, Bruce JN, Butler W, Cahill DP, Carter B, Orringer DA, Roberts DW, Sagher O, Sanai N, Schwartz TH, Silbergeld DL, Sisti MB, Thompson RC, Waziri AE, Ghogawala Z, McKhann G 2n (2017). Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study. Neurosurgery, 80(4), 590-601.
  151. Saugstad JA, Lusardi TA, Van Keuren-Jensen KR, Phillips JI, Lind B, Harrington CA, McFarland TJ, Courtright AL, Reiman RA, Yeri AS, Kalani MYS, Adelson PD, Arango J, Nolan JP, Duggan E, Messer K, Akers JC, Galasko DR, Quinn JF, Carter BS, Hochberg F (2017). Analysis of extracellular RNA in cerebrospinal fluid. Journal of extracellular vesicles, 6(1), 1317577.
  152. Hirshman BR, Wilson B, Ali MA, Proudfoot JA, Koiso T, Nagano O, Carter BS, Serizawa T, Yamamoto M, Chen C (2018). Superior Prognostic Value of Cumulative Intracranial Tumor Volume Relative to Largest Intracranial Tumor Volume for Stereotactic Radiosurgery-Treated Brain Metastasis Patients. Neurosurgery, 82(4), 473-480.
  153. Ali MA, Hirshman BR, Wilson B, Carroll KT, Proudfoot JA, Goetsch SJ, Alksne JF, Ott K, Aiyama H, Nagano O, Carter BS, Fogarty G, Hong A, Serizawa T, Yamamoto M, Chen C (2017). Survival Patterns of 5750 Stereotactic Radiosurgery-Treated Patients with Brain Metastasis as a Function of the Number of Lesions. World neurosurgery, 107, 944-951.e1.
  154. Ali MA, Hirshman BR, Wilson B, Schupper AJ, Joshi R, Proudfoot JA, Goetsch SJ, Alksne JF, Ott K, Aiyama H, Nagano O, Carter BS, Chiang V, Serizawa T, Yamamoto M, Chen C (2017). Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume. World neurosurgery, 108, 151-156.
  155. Alattar AA, Brandel MG, Hirshman BR, Dong X, Carroll KT, Ali MA, Carter BS, Chen C (2018). Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis. Journal of neurosurgery, 128(4), 1076-1083.
  156. Alattar AA, Hirshman BR, McCutcheon BA, Chen CC, Alexander T, Harris J, Carter B (2018). Risk Factors for Readmission with Cerebrospinal Fluid Leakage Within 30 Days of Vestibular Schwannoma Surgery. Neurosurgery, 82(5), 630-637.
  157. Ibsen SD, Wright J, Lewis JM, Kim S, Ko SY, Ong J, Manouchehri S, Vyas A, Akers J, Chen CC, Carter BS, Esener SC, Heller M (2017). Rapid Isolation and Detection of Exosomes and Associated Biomarkers from Plasma. ACS nano, 11(7), 6641-6651.
  158. McCutcheon BA, Hirshman BR, Gabel BC, Heffner MW, Marcus LP, Cole TS, Chen CC, Chang DC, Carter B (2018). Impact of neurosurgeon specialization on patient outcomes for intracranial and spinal surgery: a retrospective analysis of the Nationwide Inpatient Sample 1998-2009. Journal of neurosurgery, 128(5), 1578-1588.
  159. Adhikari B, Li J, Brandel MG, Futalan D, Akers J, Deming T, Chen CC, Carter B (2017). The use of TMZ embedded hydrogels for the treatment of orthotopic human glioma xenografts. Journal of clinical neuroscience, 45, 288-292.
  160. Akers JC, Hua W, Li H, Ramakrishnan V, Yang Z, Quan K, Zhu W, Li J, Figueroa J, Hirshman BR, Miller B, Piccioni D, Ringel F, Komotar R, Messer K, Galasko DR, Hochberg F, Mao Y, Carter BS, Chen C (2017). A cerebrospinal fluid microRNA signature as biomarker for glioblastoma. Oncotarget, 8(40), 68769-68779.
  161. Hirshman BR, Wilson BR, Ali MA, Schupper AJ, Proudfoot JA, Goetsch SJ, Carter BS, Sinclair G, Bartek J Jr, Chiang V, Fogarty G, Hong A, Chen C (2018). Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases. Neurosurgery, 83(2), 237-244.
  162. Wei Z, Batagov AO, Schinelli S, Wang J, Wang Y, El Fatimy R, Rabinovsky R, Balaj L, Chen CC, Hochberg F, Carter B, Breakefield XO, Krichevsky A (2017). Coding and noncoding landscape of extracellular RNA released by human glioma stem cells. Nature communications, 8(1), 1145.
  163. Ali MA, Hirshman BR, Wilson B, Schupper AJ, Joshi R, Proudfoot JA, Goetsch SJ, Alksne JF, Ott K, Aiyama H, Nagano O, Carter BS, Chiang V, Serizawa T, Yamamoto M, Chen C (2017). Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume. World neurosurgery, 108, 151-156.
  164. Kang KH, Schapira E, Niemierko A, Martinez-Lage M, Bussière MR, Yock TI, Loeffler JS, Butler WE, Carter BS, Shih H (2018). The role of proton beam therapy in central neurocytoma: A single-institution experience. Practical radiation oncology, 8(5), e305-e311.
  165. Koga T, Li B, Figueroa JM, Ren B, Chen CC, Carter BS, Furnari F (2018). Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development. Neuro-oncology, 20(10), 1310-1320.
  166. Sonntag KC, Song B, Lee N, Jung JH, Cha Y, Leblanc P, Neff C, Kong SW, Carter BS, Schweitzer J, Kim K (2018). Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. Progress in neurobiology, 168, 1-20.
  167. Ricklefs FL, Alayo Q, Krenzlin H, Mahmoud AB, Speranza MC, Nakashima H, Hayes JL, Lee K, Balaj L, Passaro C, Rooj AK, Krasemann S, Carter BS, Chen CC, Steed T, Treiber J, Rodig S, Yang K, Nakano I, Lee H, Weissleder R, Breakefield XO, Godlewski J, Westphal M, Lamszus K, Freeman GJ, Bronisz A, Lawler SE, Chiocca E (2018). Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Science advances, 4(3), eaar2766.
  168. Steed TC, Treiber JM, Brandel MG, Patel KS, Dale AM, Carter BS, Chen C (2018). Quantification of glioblastoma mass effect by lateral ventricle displacement. Scientific reports, 8(1), 2827.
  169. Carroll KT, Lochte BC, Chen JY, Snyder VS, Carter BS, Chen C (2018). Intraoperative Magnetic Resonance Imaging-Guided Biopsy in the Diagnosis of Suprasellar Langerhans Cell Histiocytosis. World neurosurgery, 112, 6-13.
  170. Carroll KT, Bryant AK, Hirshman B, Alattar AA, Joshi R, Gabel B, Carter BS, Harismendy O, Vaida F, Chen C (2018). Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total Resection. World neurosurgery, 111, e790-e798.
  171. Sahin A, Sanchez C, Bullain S, Waterman P, Weissleder R, Carter B (2018). Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma. PloS one, 13(7), e0199414.
  172. Treiber JM, Steed TC, Brandel MG, Patel KS, Dale AM, Carter BS, Chen C (2018). Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA). Journal of clinical neuroscience, 55, 86-92.
  173. Hermiz J, Rogers N, Kaestner E, Ganji M, Cleary DR, Carter BS, Barba D, Dayeh SA, Halgren E, Gilja (2018). Sub-millimeter ECoG pitch in human enables higher fidelity cognitive neural state estimation. NeuroImage, 176, 454-464.
  174. Cloughesy TF, Landolfi J, Vogelbaum MA, Ostertag D, Elder JB, Bloomfield S, Carter B, Chen CC, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu P, Piccioni D, Accomando W, Diago OR, Hogan DJ, Gammon D, Kasahara N, Kheoh T, Jolly DJ, Gruber HE, Das A, Walbert (2018). Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC. Neuro-oncology, 20(10), 1383-1392.
  175. Rogers N, Hermiz J, Ganji M, Kaestner E, K'l¿ç K, Hossain L, Thunemann M, Cleary DR, Carter BS, Barba D, Devor A, Halgren E, Dayeh SA, Gilja (2019). Correlation Structure in Micro-ECoG Recordings is Described by Spatially Coherent Components. PLoS computational biology, 15(2), e1006769.
  176. Alattar AA, Carroll KT, Bryant AK, Hirshman B, Joshi R, Carter BS, Harismendy O, Chen C (2019). Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database. World neurosurgery, 121, e411-e418.
  177. Dineen J, Maus DC, Muzyka I, See RB, Cahill DP, Carter BS, Curry WT, Jones PS, Nahed BV, Peterfreund RA, Simon M (2019). Factors that modify the risk of intraoperative seizures triggered by electrical stimulation during supratentorial functional mapping. Clinical neurophysiology, 130(6), 1058-1065.
  178. Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, Dewitt J, Gritsch S, Perez EM, Gonzalez Castro LN, Lan X, Druck N, Rodman C, Dionne D, Kaplan A, Bertalan MS, Small J, Pelton K, Becker S, Bonal D, Nguyen QD, Servis RL, Fung JM, Mylvaganam R, Mayr L, Gojo J, Haberler C, Geyeregger R, Czech T, Slavc I, Nahed BV, Curry WT, Carter BS, Wakimoto H, Brastianos PK, Batchelor TT, Stemmer-Rachamimov A, Martinez-Lage M, Frosch MP, Stamenkovic I, Riggi N, Rheinbay E, Monje M, Rozenblatt-Rosen O, Cahill DP, Patel AP, Hunter T, Verma IM, Ligon KL, Louis DN, Regev A, Bernstein BE, Tirosh I, Suvà M (2019). An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell, 178(4), 835-849.e21.
  179. Choi BD, Yu X, Castano AP, Darr H, Henderson DB, Bouffard AA, Larson RC, Scarfò I, Bailey SR, Gerhard GM, Frigault MJ, Leick MB, Schmidts A, Sagert JG, Curry WT, Carter BS, Maus M (2019). CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. Journal for immunotherapy of cancer, 7(1), 304.
  180. Choi BD, Yu X, Castano AP, Bouffard AA, Schmidts A, Larson RC, Bailey SR, Boroughs AC, Frigault MJ, Leick MB, Scarfò I, Cetrulo CL, Demehri S, Nahed BV, Cahill DP, Wakimoto H, Curry WT, Carter BS, Maus M (2019). CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nature biotechnology, 37(9), 1049-1058.
  181. Pulli B, Chapman PH, Ogilvy CS, Patel AB, Stapleton CJ, Leslie-Mazwi TM, Hirsch JA, Carter BS, Rabinov J (2019). Multimodal cerebral arteriovenous malformation treatment: a 12-year experience and comparison of key outcomes to ARUBA. Journal of neurosurgery, 133(6), 1792-1801.
  182. Jones PS, Yekula A, Lansbury E, Small JL, Ayinon C, Mordecai S, Hochberg FH, Tigges J, Delcuze B, Charest A, Ghiran I, Balaj L, Carter B (2019). Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma. EBioMedicine, 48, 23-35.
  183. Lopez Ramos C, Williams JE, Bababekov YJ, Chang DC, Carter BS, Jones P (2019). Assessing the Understandability and Actionability of Online Neurosurgical Patient Education Materials. World neurosurgery, 130, e588-e597.
  184. Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen BM, Teicher MH, Leblanc P, Carter BS, Kordower JH, Bolshakov VY, Kong SW, Schweitzer JS, Kim K (2020). Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models. The Journal of clinical investigation, 130(2), 904-920.
  185. Workman AD, Welling DB, Carter BS, Curry WT, Holbrook EH, Gray ST, Scangas GA, Bleier B (2020). Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies. International forum of allergy & rhinology, 10(7), 798-805.
  186. Schweitzer JS, Song B, Leblanc PR, Feitosa M, Carter BS, Kim K (2020). Columnar Injection for Intracerebral Cell Therapy. Operative neurosurgery (Hagerstown, Md.), 18(3), 321-328.
  187. Wang L, Yekula A, Muralidharan K, Small JL, Rosh ZS, Kang KM, Carter BS, Balaj (2020). Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma. Cancers, 12(5),
  188. Ramakrishnan V, Xu B, Akers J, Nguyen T, Ma J, Dhawan S, Ning J, Mao Y, Hua W, Kokkoli E, Furnari F, Carter BS, Chen C (2020). Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas. EBioMedicine, 55, 102736.
  189. Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, Kim K (2020). Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease. The New England journal of medicine, 382(20), 1926-1932.
  190. Steed TC, Treiber JM, Taha B, Engin HB, Carter H, Patel KS, Dale AM, Carter BS, Chen C (2020). Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state. Journal of neuro-oncology, 148(3), 455-462.
  191. Workman AD, Jafari A, Welling DB, Varvares MA, Gray ST, Holbrook EH, Scangas GA, Xiao R, Carter BS, Curry WT, Bleier B (2020). Airborne Aerosol Generation During Endonasal Procedures in the Era of COVID-19: Risks and Recommendations. Otolaryngology--head and neck surgery, 163(3), 465-470.
  192. Muhlestein WE, Monsour MA, Friedman GN, Zinzuwadia A, Zachariah MA, Coumans JV, Carter BS, Chambless L (2021). Predicting Discharge Disposition Following Meningioma Resection Using a Multi-Institutional Natural Language Processing Model. Neurosurgery, 88(4), 838-845.
  193. Maas SLN, van Solinge TS, Schnoor R, Yekula A, Senders JT, de Vrij J, Robe P, Carter BS, Balaj L, Arkesteijn GJA, Nolte-'t Hoen ENM, Broekman ML (2020). Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients. Cancers, 12(11),
  194. Muralidharan K, Yekula A, Small JL, Rosh ZS, Kang KM, Wang L, Lau S, Zhang H, Lee H, Bettegowda C, Chicoine MR, Kalkanis SN, Shankar GM, Nahed BV, Curry WT, Jones PS, Cahill DP, Balaj L, Carter B (2021). TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas. Clinical cancer research, 27(1), 169-178.
  195. Steed TC, Treiber JM, Taha B, Engin HB, Carter H, Patel KS, Dale AM, Carter BS, Chen C (2020). Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state. Journal of neuro-oncology, 148(3), 455-462.
  196. Simon MV, Curry WT, Jones PS, Cahill DP, Carter BS, Rapalino O, Malik AN, Nahed B (2021). Intraoperative thalamocortical tract monitoring via direct cortical recordings during craniotomy. Clinical neurophysiology, 132(7), 1416-1432.
  197. Kang KM, Muralidharan K, Yekula A, Small JL, Rosh ZS, Jones PS, Carter BS, Balaj (2021). Blood-Based Detection of BRAF V600E in Gliomas and Brain Tumor Metastasis. Cancers, 13(6),
  198. Park J, Park JS, Huang CH, Jo A, Cook K, Wang R, Lin HY, Van Deun J, Li H, Min J, Wang L, Yoon G, Carter BS, Balaj L, Choi GS, Castro CM, Weissleder R, Lee (2021). An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma. Nature biomedical engineering, 5(7), 678-689.
  199. Khalafallah AM, Rakovec M, Bettegowda C, Jackson CM, Gallia GL, Weingart JD, Lim M, Esquenazi Y, Zacharia BE, Goldschmidt E, Ziu M, Ivan ME, Venteicher AS, Nduom EK, Mamelak AN, Chu RM, Yu JS, Sheehan JP, Nahed BV, Carter BS, Berger MS, Sawaya R, Mukherjee (2021). A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma. Neurosurgery, 89(4), 712-719.
  200. Schupper AJ, Baron RB, Cheung W, Rodriguez J, Kalkanis SN, Chohan MO, Andersen BJ, Chamoun R, Nahed BV, Zacharia BE, Kennedy J, Moulding HD, Zucker L, Chicoine MR, Olson JJ, Jensen RL, Sherman JH, Zhang X, Price G, Fowkes M, Germano IM, Carter BS, Hadjipanayis CG, Yong R (2021). 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study. Journal of neurosurgery, 136(6), 1525-1534.
  201. Kilic T, Cho YK, Jeong N, Shin IS, Carter BS, Balaj L, Weissleder R, Lee (2022). Multielectrode Spectroscopy Enables Rapid and Sensitive Molecular Profiling of Extracellular Vesicles. ACS central science, 8(1), 110-117.
  202. Duy PQ, Weise SC, Marini C, Li XJ, Liang D, Dahl PJ, Ma S, Spajic A, Dong W, Juusola J, Kiziltug E, Kundishora AJ, Koundal S, Pedram MZ, Torres-Fernández LA, Händler K, De Domenico E, Becker M, Ulas T, Juranek SA, Cuevas E, Hao LT, Jux B, Sousa AMM, Liu F, Kim SK, Li M, Yang Y, Takeo Y, Duque A, Nelson-Williams C, Ha Y, Selvaganesan K, Robert SM, Singh AK, Allington G, Furey CG, Timberlake AT, Reeves BC, Smith H, Dunbar A, DeSpenza T Jr, Goto J, Marlier A, Moreno-De-Luca A, Yu X, Butler WE, Carter BS, Lake EMR, Constable RT, Rakic P, Lin H, Deniz E, Benveniste H, Malvankar NS, Estrada-Veras JI, Walsh CA, Alper SL, Schultze JL, Paeschke K, Doetzlhofer A, Wulczyn FG, Jin SC, Lifton RP, Sestan N, Kolanus W, Kahle K (2022). Impaired neurogenesis alters brain biomechanics in a neuroprogenitor-based genetic subtype of congenital hydrocephalus. Nature neuroscience, 25(4), 458-473.
  203. Yeo AT, Rawal S, Delcuze B, Christofides A, Atayde A, Strauss L, Balaj L, Rogers VA, Uhlmann EJ, Varma H, Carter BS, Boussiotis VA, Charest (2022). Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression. Nature immunology, 23(6), 971-984.
  204. Hsia T, Yekula A, Batool SM, Rosenfeld YB, You DG, Weissleder R, Lee H, Carter BS, Balaj (2022). Glioblastoma-derived extracellular vesicle subpopulations following 5-aminolevulinic acid treatment bear diagnostic implications. Journal of extracellular vesicles, 11(11), e12278.
  205. Batool SM, Muralidharan K, Hsia T, Falotico S, Gamblin AS, Rosenfeld YB, Khanna SK, Balaj L, Carter B (2022). Highly Sensitive EGFRvIII Detection in Circulating Extracellular Vesicle RNA of Glioma Patients. Clinical cancer research, 28(18), 4070-4082.
  206. Batool SM, Hsia T, Beecroft A, Lewis B, Ekanayake E, Rosenfeld Y, Escobedo AK, Gamblin AS, Rawal S, Cote RJ, Watson M, Wong DTW, Patel AA, Skog J, Papadopoulos N, Bettegowda C, Castro CM, Lee H, Srivastava S, Carter BS, Balaj (2023). Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer. Cell reports. Medicine, 4(10), 101196.
  207. Batool SM, Yekula A, Khanna P, Hsia T, Gamblin AS, Ekanayake E, Escobedo AK, You DG, Castro CM, Im H, Kilic T, Garlin MA, Skog J, Dinulescu DM, Dudley J, Agrawal N, Cheng J, Abtin F, Aberle DR, Chia D, Elashoff D, Grognan T, Krysan K, Oh SS, Strom C, Tu M, Wei F, Xian RR, Skates SJ, Zhang DY, Trinh T, Watson M, Aft R, Rawal S, Agarwal A, Kesmodel SB, Yang C, Shen C, Hochberg FH, Wong DTW, Patel AA, Papadopoulos N, Bettegowda C, Cote RJ, Srivastava S, Lee H, Carter BS, Balaj (2023). The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. Cell reports. Medicine, 4(10), 101198.
  208. Hsia T, You DG, Politis MG, Batool SM, Ekanayake E, Lee H, Carter BS, Balaj (2024). Rigorous Comparison of Extracellular Vesicle Processing to Enhance Downstream Analysis for Glioblastoma Characterization. Advanced biology, 8(1), e2300233.
  209. Hsia T, Small JL, Yekula A, Batool SM, Escobedo AK, Ekanayake E, You DG, Lee H, Carter BS, Balaj (2023). Systematic Review of Photodynamic Therapy in Gliomas. Cancers, 15(15),
  210. Yekula A, Sreeram S, Dhawan S, Sharma M, Sandoval-Garcia C, Huling JD, Suri A, Belani K, Park MC, Carter BS, Chen C (2023). Neurosurgery residency match for international medical graduates in the United States. Journal of neurosurgery, 140(1), 291-298.
  211. Park TY, Jeon J, Lee N, Kim J, Song B, Kim JH, Lee SK, Liu D, Cha Y, Kim M, Leblanc P, Herrington TM, Carter BS, Schweitzer JS, Kim K (2023). Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson's disease. Nature, 619(7970), 606-615.
  212. Batool SM, Yekula A, Khanna P, Hsia T, Gamblin AS, Ekanayake E, Escobedo AK, You DG, Castro CM, Im H, Kilic T, Garlin MA, Skog J, Dinulescu DM, Dudley J, Agrawal N, Cheng J, Abtin F, Aberle DR, Chia D, Elashoff D, Grognan T, Krysan K, Oh SS, Strom C, Tu M, Wei F, Xian RR, Skates SJ, Zhang DY, Trinh T, Watson M, Aft R, Rawal S, Agarwal A, Kesmodel SB, Yang C, Shen C, Hochberg FH, Wong DTW, Patel AA, Papadopoulos N, Bettegowda C, Cote RJ, Srivastava S, Lee H, Carter BS, Balaj (2023). The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. Cell reports. Medicine, 4(10), 101198.
  213. Batool SM, Hsia T, Beecroft A, Lewis B, Ekanayake E, Rosenfeld Y, Escobedo AK, Gamblin AS, Rawal S, Cote RJ, Watson M, Wong DTW, Patel AA, Skog J, Papadopoulos N, Bettegowda C, Castro CM, Lee H, Srivastava S, Carter BS, Balaj (2023). Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer. Cell reports. Medicine, 4(10), 101196.
  214. Yekula A, Hsia T, Kitchen RR, Chakrabortty SK, Yu W, Batool SM, Lewis B, Szeglowski AJ, Weissleder R, Lee H, Chi AS, Batchelor T, Carter BS, Breakefield XO, Skog J, Balaj (2023). Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients. Neuro-oncology advances, 5(1), vdad104.
  215. Zhao S, Mekbib KY, van der Ent MA, Allington G, Prendergast A, Chau JE, Smith H, Shohfi J, Ocken J, Duran D, Furey CG, Hao LT, Duy PQ, Reeves BC, Zhang J, Nelson-Williams C, Chen D, Li B, Nottoli T, Bai S, Rolle M, Zeng X, Dong W, Fu PY, Wang YC, Mane S, Piwowarczyk P, Fehnel KP, See AP, Iskandar BJ, Aagaard-Kienitz B, Moyer QJ, Dennis E, Kiziltug E, Kundishora AJ, DeSpenza T Jr, Greenberg ABW, Kidanemariam SM, Hale AT, Johnston JM, Jackson EM, Storm PB, Lang SS, Butler WE, Carter BS, Chapman P, Stapleton CJ, Patel AB, Rodesch G, Smajda S, Berenstein A, Barak T, Erson-Omay EZ, Zhao H, Moreno-De-Luca A, Proctor MR, Smith ER, Orbach DB, Alper SL, Nicoli S, Boggon TJ, Lifton RP, Gunel M, King PD, Jin SC, Kahle K (2023). Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations. Nature communications, 14(1), 7452.
  216. Hsia T, You DG, Politis MG, Batool SM, Ekanayake E, Lee H, Carter BS, Balaj (2024). Rigorous Comparison of Extracellular Vesicle Processing to Enhance Downstream Analysis for Glioblastoma Characterization. Advanced biology, 8(1), e2300233.
  217. Ramapriyan R, Ramesh T, Yu H, Richardson LG, Nahed BV, Carter BS, Barker FG, Curry WT, Choi B (2023). County-level disparities in care for patients with glioblastoma. Neurosurgical focus, 55(5), E12.
  218. Wang AZ, Mashimo BL, Schaettler MO, Sherpa ND, Leavitt LA, Livingstone AJ, Khan SM, Li M, Anzaldua-Campos MI, Bradley JD, Leuthardt EC, Kim AH, Dowling JL, Chicoine MR, Jones PS, Choi BD, Cahill DP, Carter BS, Petti AA, Johanns TM, Dunn G (2024). Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population. Cancer discovery, 14(6), 1106-1131.
  219. Choi BD, Gerstner ER, Frigault MJ, Leick MB, Mount CW, Balaj L, Nikiforow S, Carter BS, Curry WT, Gallagher K, Maus M (2024). Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma. The New England journal of medicine, 390(14), 1290-1298.
  220. Massaad E, Smith WJ, Bradley J, Esposito E, Gupta M, Burns E, Burns R, Velarde JK, Berglar IK, Gupta R, Martinez-Lage M, Dietrich J, Lennerz JK, Dunn GP, Jones PS, Choi BD, Kim AE, Frosch M, Barker FG, Curry WT, Carter BS, Nahed BV, Cahill DP, Shankar G (2024). Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma. Neuro-oncology, 26(9), 1660-1669.
  221. Choi BD, Carter B (2022). Engineering Our Future: Advancing Cell and Gene Therapy in Neurosurgery. Neurosurgery, 68(Suppl 1), 11-16.
  222. Brown JM, Mahan MA, Mandeville R, Carter B (2017). Establishing reconstructive neurosurgery as a subspecialty. Neurosurgical focus, 43(1), E7.

Review

  1. Sonntag KC, Song B, Lee N, Jung JH, Cha Y, Leblanc P, Neff C, Kong SW, Carter BS, Schweitzer J, Kim K (2018). Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. Progress in neurobiology, 168, 1-20.
  2. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh P (1993). Hereditary prostate cancer: epidemiologic and clinical features. The Journal of urology, 150(3), 797-802.
  3. Ng K, Kim R, Kesari S, Carter B, Chen C (2012). Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights. Journal of neuro-oncology, 107(1), 1-12.
  4. Patel KS, Dhawan S, Wang R, Carter BS, Chen JY, Chen C (2018). Post-operative imaging assessment of non-functioning pituitary adenomas. Acta neurochirurgica, 160(5), 1029-1039.
  5. Dhawan S, Venteicher AS, Butler WE, Carter BS, Chen C (2021). Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis. Journal of neuro-oncology, 154(1), 1-11.
  6. McDonald C, Carter B (2002). Medical management of increased intracranial pressure after spontaneous intracerebral hemorrhage. Neurosurgery clinics of North America, 13(3), 335-8.
  7. Hochberg FH, Atai NA, Gonda D, Hughes MS, Mawejje B, Balaj L, Carter R (2014). Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science. Expert review of molecular diagnostics, 14(4), 439-52.
  8. Santiago-Dieppa DR, Steinberg J, Gonda D, Cheung VJ, Carter BS, Chen C (2014). Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients. Expert review of molecular diagnostics, 14(7), 819-25.
  9. Rennert RC, Hochberg FH, Carter B (2016). ExRNA in Biofluids as Biomarkers for Brain Tumors. Cellular and molecular neurobiology, 36(3), 353-60.
  10. Rennert RC, Santiago-Dieppa DR, Figueroa J, Sanai N, Carter B (2016). Future directions of operative neuro-oncology. Journal of neuro-oncology, 130(2), 377-382.
  11. Hirshman BR, Kras RT, Akers JC, Carter BS, Chen C (2016). Extracellular Vesicles in Molecular Diagnostics: An Overview with a Focus on CNS Diseases. Advances in clinical chemistry, 76, 37-53.
  12. van Vugt VA, Kesari A, Muller KA, Carter B, Vandenberg SR, Kesari (2016). A 22-Year Old Woman with Right Eyelid Swelling. Brain pathology (Zurich, Switzerland), 26(3), 425-6.
  13. Shankar GM, Balaj L, Stott SL, Nahed B, Carter B (2017). Liquid biopsy for brain tumors. Expert review of molecular diagnostics, 17(10), 943-947.
  14. Patel KS, Carter BS, Chen C (2018). Role of Biopsies in the Management of Intracranial Gliomas. Progress in neurological surgery, 30, 232-243.
  15. Santiago-Dieppa DR, Gonda DD, Cheung VJ, Steinberg JA, Carter BS, Chen C (2018). Extracellular Vesicles as a Platform for Glioma Therapeutic Development. Progress in neurological surgery, 32, 172-179.
  16. Roy S, Lin HY, Chou CY, Huang CH, Small J, Sadik N, Ayinon CM, Lansbury E, Cruz L, Yekula A, Jones PS, Balaj L, Carter B (2019). Navigating the Landscape of Tumor Extracellular Vesicle Heterogeneity. International journal of molecular sciences, 20(6),
  17. Yekula A, Muralidharan K, Kang KM, Wang L, Balaj L, Carter B (2020). From laboratory to clinic: Translation of extracellular vesicle based cancer biomarkers. Methods (San Diego, Calif.), 177, 58-66.
  18. Yekula A, Yekula A, Muralidharan K, Kang K, Carter BS, Balaj (2020). Extracellular Vesicles in Glioblastoma Tumor Microenvironment. Frontiers in immunology, 10, 3137.
  19. Kozin ED, Remenschneider AK, Blevins NH, Jan TA, Quesnel AM, Chari DA, Kesser BW, Weinstein JE, Ahsan SF, Telischi FF, Adunka OF, Weber P, Knoll RM, Coelho DH, Anne S, Franck KH, Marchioni D, Barker FG 2nd, Carter BS, Lustig LR, Bojrab DI, Bhansali SA, Westerberg BD, Lundy L, Jackler RK, Roland JT Jr, Chandrasekhar SS, Antonelli PJ, Carey JP, Welling DB, Slattery WH 3rd, Lee DJ, members of the American Neurotology Society Council, members of the American Otological Society Council, and members of the American Academy of Otolaryngology ¿ Head and Neck Surgery Hearing Committee and Implantable Hearing Devices Committe (2020). American Neurotology Society, American Otological Society, and American Academy of Otolaryngology - Head and Neck Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic. Otology & neurotology, 41(9), 1163-1174.
  20. Yekula A, Muralidharan K, Rosh ZS, Youngkin AE, Kang KM, Balaj L, Carter B (2020). Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas. Advanced biosystems, 4(12), e2000029.
  21. Batool SM, Hsia T, Khanna SK, Gamblin AS, Rosenfeld Y, You DG, Carter BS, Balaj (2022). Decoding vesicle-based precision oncology in gliomas. Neuro-oncology advances, 4(Suppl 2), ii53-ii60.
  22. Hsia T, Small JL, Yekula A, Batool SM, Escobedo AK, Ekanayake E, You DG, Lee H, Carter BS, Balaj (2023). Systematic Review of Photodynamic Therapy in Gliomas. Cancers, 15(15),

Case Report

  1. Carter BS, Rabinov JD, Pfannl R, Schwamm L (2004). Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 5-2004 - a 57-year-old man with slurred speech and left hemiparesis. The New England journal of medicine, 350(7), 707-16.
  2. Mahta A, Du Z, Borys E, Carter B, Vandenberg SR, Kesari (2013). 78 year old male with dysphagia and dysarthria. Brain pathology (Zurich, Switzerland), 23(6), 705-6.

Editorial

  1. Salehi A, Chen CC, Carter B (2012). Viral vectors: promising new therapeutics in the battle against glioblastoma. Expert review of clinical pharmacology, 5(5), 489-91.
  2. Carter BS, Chiocca E (2020). Editorial. COVID-19 and academic neurosurgery. Journal of neurosurgery, 133(1), 8-9.

Letter

  1. Herrington TM, Schweitzer J, Henchcliffe C, Carter BS, Kim K (2020). Toward a Personalized Approach to Parkinson's Cell Therapy. Movement disorders, 35(11), 2119-2120.
  2. Schweitzer JS, Herrington TM, Kim KS, Carter B (2022). Letter to the Editor. Cell therapy for Parkinson's disease. Journal of neurosurgery, 136(6), 1810-1811.
  3. Schweitzer JS, Herrington TM, Kim KS, Carter B (2022). Letter to the Editor. Cell therapy for Parkinson's disease. Journal of neurosurgery, 136(6), 1810-1811.

Other

  1. Carter BS, Chiocca EA, Lonser R, Kaye AH, de Tribolet (2015). Introduction: a focus on low-grade glioma. Neurosurgical focus, 38(1), E2.
  2. Wilson BR, Steinberg JA, Snyder V, Jiang MN, Carter B (2016). Histologic Evidence for Arteriovenous Malformation-Like Vasculature Occurring within an Intracerebral Schwannoma: A Case Report and Review of the Literature. World neurosurgery, 92, 582.e9-582.e13.
  3. Akers JC, Gonda D, Kim R, Carter BS, Chen C (2013). Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. Journal of neuro-oncology, 113(1), 1-11.
  4. Chen CC, Carter BS, Wang R, Patel KS, Hess C, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, Litvack Z, Zada G, Aghi M (2016). Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Preoperative Imaging Assessment of Patients With Suspected Nonfunctioning Pituitary Adenomas. Neurosurgery, 79(4), E524-6.
  5. Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM, Oyesiku NM, Patel KS, Wang R, Carter BS, Chen JY, Chen CC, Patil CG, Litvack Z, Zada G, Aghi M (2016). Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas. Neurosurgery, 79(4), E541-3.
  6. Wijdicks EF, Sheth KN, Carter BS, Greer DM, Kasner SE, Kimberly WT, Schwab S, Smith EE, Tamargo RJ, Wintermark M, American Heart Association Stroke Counci (2014). Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45(4), 1222-38.

News & Podcasts

News